Zacks Investment Management’s Athenahealth, Inc. ATHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-6,958
Closed -$930K 620
2018
Q3
$930K Sell
6,958
-8,015
-54% -$1.2M 0.02% 405
2018
Q2
$2.38M Buy
14,973
+2,370
+19% +$351K 0.05% 243
2018
Q1
$1.8M Buy
+12,603
New +$1.72M 0.04% 286
2016
Q3
Sell
-6,040
Closed -$834K 763
2016
Q2
$834K Sell
6,040
-496
-8% -$65.6K 0.03% 365
2016
Q1
$907K Buy
6,536
+2,424
+59% +$332K 0.03% 341
2015
Q4
$662K Buy
+4,112
New +$635K 0.02% 379
2015
Q3
Sell
-2,686
Closed -$308K 715
2015
Q2
$308K Buy
+2,686
New +$321K 0.01% 526

Other funds holding ATHN

Zacks Investment Management's ATHN Position: Q4 2018 in Review

Zacks Investment Management sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 6,958 shares — an estimated $930K sold.

Zacks Investment Management first reported a position in ATHN in Q2 2015 and held it in 7 quarters. The position peaked at $2.38M in Q2 2018. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

  • Zacks Investment Management reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
  • Zacks Investment Management sold 6,958 Athenahealth, Inc. shares in Q4 2018, an estimated $930K.
  • Zacks Investment Management first reported a position in Athenahealth, Inc. in Q2 2015 and held it in 7 quarters.
  • Zacks Investment Management's Athenahealth, Inc. position peaked at $2.38M in Q2 2018.
  • 263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Zacks Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.